Cite
Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.
MLA
Tsao, Ming-Sound, et al. “Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 6, no. 1, Jan. 2011, pp. 139–47. EBSCOhost, https://doi.org/10.1097/JTO.0b013e3181fd83a4.
APA
Tsao, M.-S., Sakurada, A., Ding, K., Aviel-Ronen, S., Ludkovski, O., Liu, N., Le Maître, A., Gandara, D., Johnson, D. H., Rigas, J. R., Seymour, L., & Shepherd, F. A. (2011). Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 6(1), 139–147. https://doi.org/10.1097/JTO.0b013e3181fd83a4
Chicago
Tsao, Ming-Sound, Akira Sakurada, Keyue Ding, Sarit Aviel-Ronen, Olga Ludkovski, Ni Liu, Aurélie Le Maître, et al. 2011. “Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 6 (1): 139–47. doi:10.1097/JTO.0b013e3181fd83a4.